409 results on '"von Bueren, André O"'
Search Results
2. General support of physical exercise programs in pediatric oncology but differences in perception by childhood cancer care professionals at European and North-African/Arab centers
3. European standard clinical practice recommendations for paediatric high-grade gliomas
4. MSH2, MSH6, MLH1, and PMS2 immunohistochemistry as highly sensitive screening method for DNA mismatch repair deficiency syndromes in pediatric high-grade glioma
5. How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
6. Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies
7. Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma – A Report From the HIT 2000 Trial
8. Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile
9. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.
10. Treatment-related survival patterns in diffuse intrinsic pontine glioma using a historical cohort: A Report from the European Society for Pediatric Oncology DIPG/DMG Registry
11. Gliomatosis cerebri in children:A poor prognostic phenotype of diffuse gliomas with a distinct molecul profile
12. Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience
13. Role of molecular adsorbent recirculating system in methotrexate-induced acute liver failure: a case report and literature review.
14. Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.
15. Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
16. Haematological malignancies following temozolomide treatment for paediatric high-grade glioma
17. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group
18. Concurrent radiotherapy with temozolomide vs. concurrent radiotherapy with a cisplatinum-based polychemotherapy regimen: Acute toxicity in pediatric high-grade glioma patients
19. Next-generation personalised medicine for high-risk paediatric cancer patients – The INFORM pilot study
20. Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome
21. Pediatric oncologists' perspectives on the use of complementary medicine in pediatric cancer patients in Switzerland: A national survey-based cross-sectional study
22. Pediatric oncologists' perspectives on the use of complementary medicine in pediatric cancer patients in Switzerland: A national survey-based cross-sectional study
23. Post‐traumatic growth in parents of long‐term childhood cancer survivors compared to the general population: A report from the Swiss childhood cancer survivor study—Parents.
24. Pediatric Posterior Fossa ATRT: A Case Report, New Treatment Strategies and Perspectives
25. Supplementary Table from The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
26. Data from The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
27. Supplementary Figure from The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
28. Supplementary Figures S1-S2 from Targeting the Phosphoinositide 3-Kinase Isoform p110δ Impairs Growth and Survival in Neuroblastoma Cells
29. Supplementary Methods, Figure Legends 1-4 from Disabling c-Myc in Childhood Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor Cells by the Potent G-Quadruplex Interactive Agent S2T1-6OTD
30. Supplementary Table 1 from Expression of FoxM1 Is Required for the Proliferation of Medulloblastoma Cells and Indicates Worse Survival of Patients
31. Supplementary Figures 1-4 from Disabling c-Myc in Childhood Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor Cells by the Potent G-Quadruplex Interactive Agent S2T1-6OTD
32. Supplementary Figure 1 from Expression of FoxM1 Is Required for the Proliferation of Medulloblastoma Cells and Indicates Worse Survival of Patients
33. Intraventricular methotrexate as part of primary therapy for children with infant and/or metastatic medulloblastoma: Feasibility, acute toxicity and evidence for efficacy
34. Metastatic medulloblastoma in adults: Outcome of patients treated according to the HIT2000 protocol
35. External validation of a prognostic model estimating the survival of patients with recurrent high-grade gliomas after reirradiation
36. A suggestion to introduce the diagnosis of “diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)”
37. Tropomyosin receptor kinase C (TrkC) expression in medulloblastoma: relation to the molecular subgroups and impact on treatment response
38. Early Childhood Medulloblastoma: Prognostic Factors
39. Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups
40. Médecine de précision dans le traitement des cancers pédiatriques
41. Reverse phase protein arrays enable glioblastoma molecular subtyping
42. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: A prospective observational multicentre study
43. Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma
44. Re-irradiation or re-operation followed by dendritic cell vaccination? Comparison of two different salvage strategies for relapsed high-grade gliomas by means of a new prognostic model
45. A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma
46. Pediatric oncologists' perspectives on the use of complementary medicine in pediatric cancer patients in Switzerland: A national survey‐based cross‐sectional study
47. HGG-29. How I treat recurrent pediatric high-grade glioma (HGG): A Europe-wide survey study.
48. HGG-49. Gliomatosis cerebri in children: A collaborative report from the European Society for Pediatric Oncology (SIOPE)
49. MEDB-41. Identifying a subgroup of patients with early childhood sonic hedgehog-activated medulloblastoma with unfavorable prognosis after treatment with radiation-sparing regimens including intraventricular methotrexate
50. MEDB-04. Young children with metastatic medulloblastoma: frequent requirement for radiotherapy in children with non-WNT/non-SHH medulloblastoma despite highly intensified chemotherapy – Results of the MET-HIT2000-BIS4 trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.